Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Boston Scientific Corporation(BSX) | 1,170,100 | 962,000 | -208,100 | $90.11M | $80.62M | 4.11% | -$9.49M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,917,231 | 2,917,231 | 0 | $75.50M | $79.87M | 4.07% | +$4.38M |
| Intuitive Surgical, Inc.(ISRG) | 245,000 | 148,200 | -96,800 | $108.99M | $72.81M | 3.71% | -$36.18M |
| Natera, Inc.(NTRA) | 766,500 | 556,400 | -210,100 | $83.00M | $70.63M | 3.60% | -$12.37M |
| CG Oncology, Inc.(CGON) | 1,296,225 | 1,656,000 | +359,775 | $40.92M | $62.48M | 3.19% | +$21.56M |
| Acadia Healthcare Company, Inc.(ACHC) | 1,120,000 | 985,000 | -135,000 | $75.64M | $62.46M | 3.19% | -$13.19M |
| Neurocrine Biosciences, Inc.(NBIX) | 491,000 | 460,000 | -31,000 | $67.60M | $53.00M | 2.70% | -$14.59M |
| UnitedHealth Group Incorporated(UNH) | 0 | 87,400 | +87,400 | $0 | $51.10M | 2.61% | +$51.10M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 544,500 | 431,000 | -113,500 | $58.11M | $48.02M | 2.45% | -$10.10M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 3,335,000 | 2,455,000 | -880,000 | $68.47M | $47.26M | 2.41% | -$21.21M |
| Perspective Therapeutics, Inc.(CATX) | 3,037,668 | 3,444,002 | +406,334 | $30.29M | $45.98M | 2.35% | +$15.69M |
| Glaukos Corporation(GKOS) | 224,000 | 344,900 | +120,900 | $26.51M | $44.93M | 2.29% | +$18.42M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,117,000 | 1,373,000 | +256,000 | $39.22M | $43.50M | 2.22% | +$4.28M |
| Insmed Incorporated(INSM) | 430,000 | 592,000 | +162,000 | $28.81M | $43.22M | 2.20% | +$14.41M |
| Thermo Fisher Scientific Inc.(TMO) | 80,000 | 68,600 | -11,400 | $44.24M | $42.43M | 2.16% | -$1.81M |
| Tenet Healthcare Corporation(THC) | 372,000 | 253,000 | -119,000 | $49.49M | $42.05M | 2.14% | -$7.44M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 960,000 | 752,000 | -208,000 | $39.46M | $41.77M | 2.13% | +$2.32M |
| Humana Inc.(HUM) | 0 | 129,700 | +129,700 | $0 | $41.08M | 2.10% | +$41.08M |
| Endeavour Silver Corp.(EXK) | 338,500 | 588,000 | +249,500 | $14.30M | $40.05M | 2.04% | +$25.75M |
| Illumina, Inc.(ILMN) | 478,000 | 292,000 | -186,000 | $49.89M | $38.08M | 1.94% | -$11.81M |
| Arvinas, Inc.(ARVN) | 2,987,845 | 1,497,000 | -1,490,845 | $79.54M | $36.87M | 1.88% | -$42.67M |
| Revolution Medicines, Inc.(RVMD) | 755,000 | 790,000 | +35,000 | $29.30M | $35.83M | 1.83% | +$6.52M |
| Centessa Pharmaceuticals PlcADS | 0 | 2,132,000 | +2,132,000 | $0 | $34.09M | 1.74% | +$34.09M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 1,620,000 | 1,804,493 | +184,493 | $16.69M | $32.63M | 1.66% | +$15.94M |
| Xenon Pharmaceuticals Inc.(XENE) | 754,000 | 818,000 | +64,000 | $29.40M | $32.20M | 1.64% | +$2.81M |
| Avantor, Inc.(AVTR) | 3,086,000 | 1,235,000 | -1,851,000 | $65.42M | $31.95M | 1.63% | -$33.47M |
| Blueprint Medicines Corp | 383,000 | 315,000 | -68,000 | $41.28M | $29.14M | 1.49% | -$12.14M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 731,104 | 731,104 | 0 | $25.00M | $28.51M | 1.45% | +$3.52M |
| Surgery Partners, Inc.(SGRY) | 1,306,477 | 827,000 | -479,477 | $31.08M | $26.66M | 1.36% | -$4.42M |
| Axsome Therapeutics, Inc.(AXSM) | 376,000 | 296,100 | -79,900 | $30.27M | $26.61M | 1.36% | -$3.66M |
| Danaher Corporation(DHR) | 150,000 | 95,000 | -55,000 | $37.48M | $26.41M | 1.35% | -$11.07M |
| Janux Therapeutics, Inc.(JANX) | 840,219 | 562,000 | -278,219 | $35.20M | $25.53M | 1.30% | -$9.67M |
| Neumora Therapeutics, Inc.(NMRA) | 1,800,000 | 1,800,000 | 0 | $17.69M | $23.78M | 1.21% | +$6.08M |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 500,000 | +500,000 | $0 | $23.66M | 1.21% | +$23.66M |
| Biohaven Ltd.(BHVN) | 450,000 | 465,000 | +15,000 | $15.62M | $23.24M | 1.19% | +$7.62M |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 320,000 | +320,000 | $0 | $22.49M | 1.15% | +$22.49M |
| argenx SEADR(ARGX) | 60,500 | 38,200 | -22,300 | $26.02M | $20.71M | 1.06% | -$5.31M |
| Incyte Corporation(INCY) | 529,000 | 308,110 | -220,890 | $32.07M | $20.37M | 1.04% | -$11.70M |
| AbbVie Inc.(ABBV) | 277,800 | 100,000 | -177,800 | $47.65M | $19.75M | 1.01% | -$27.90M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 790,926 | +790,926 | $0 | $19.39M | 0.99% | +$19.39M |
| Structure Therapeutics IncADS | 1,075,000 | 430,900 | -644,100 | $42.22M | $18.91M | 0.96% | -$23.30M |
| Neurogene Inc.(NGNE) | 727,537 | 425,041 | -302,496 | $26.48M | $17.83M | 0.91% | -$8.64M |
| Terns Pharmaceuticals Inc | 0 | 2,133,872 | +2,133,872 | $0 | $17.80M | 0.91% | +$17.80M |
| Ascendis Pharma A/SADR(ASND) | 0 | 119,000 | +119,000 | $0 | $17.77M | 0.91% | +$17.77M |
| BioNTech SEADS(BNTX) | 0 | 145,000 | +145,000 | $0 | $17.22M | 0.88% | +$17.22M |
| Intra-Cellular Therapies Inc | 400,000 | 233,000 | -167,000 | $27.40M | $17.05M | 0.87% | -$10.35M |
| Keros Therapeutics, Inc.(KROS) | 343,200 | 293,200 | -50,000 | $15.68M | $17.03M | 0.87% | +$1.34M |
| DexCom, Inc.(DXCM) | 259,000 | 240,000 | -19,000 | $29.37M | $16.09M | 0.82% | -$13.28M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 1,447,119 | +1,447,119 | $0 | $14.83M | 0.76% | +$14.83M |
| Newamsterdam Pharma Company ORDINARY SHARES | 559,300 | 889,700 | +330,400 | $10.74M | $14.77M | 0.75% | +$4.02M |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 7,417,155 | -2,200 | $14.88M | $14.54M | 0.74% | -$338.2K |
| Zoetis Inc.CL A(ZTS) | 0 | 71,000 | +71,000 | $0 | $13.87M | 0.71% | +$13.87M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,100,000 | 749,000 | -351,000 | $23.68M | $13.83M | 0.71% | -$9.85M |
| Immunic, Inc.(IMUX) | 8,902,972 | 8,266,000 | -636,972 | $9.88M | $13.64M | 0.70% | +$3.76M |
| Bristol-Myers Squibb Company(BMY) | 0 | 263,000 | +263,000 | $0 | $13.61M | 0.69% | +$13.61M |
| Immunome, Inc.(IMNM) | 873,891 | 873,891 | 0 | $10.57M | $12.78M | 0.65% | +$2.20M |
| REGENXBIO Inc.(RGNX) | 1,300,064 | 1,132,564 | -167,500 | $15.21M | $11.88M | 0.61% | -$3.33M |
| Cogent Biosciences, Inc.(COGT) | 1,000,706 | 1,001,000 | +294 | $8.44M | $10.81M | 0.55% | +$2.37M |
| Apogee Therapeutics Inc | 487,000 | 154,000 | -333,000 | $19.16M | $9.05M | 0.46% | -$10.12M |
| Privia Health Group, Inc.(PRVA) | 764,200 | 466,800 | -297,400 | $13.28M | $8.50M | 0.43% | -$4.78M |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 918,000 | +918,000 | $0 | $8.16M | 0.42% | +$8.16M |
| Establishment Labs Holdings Inc.(ESTA) | 531,000 | 169,000 | -362,000 | $24.13M | $7.31M | 0.37% | -$16.82M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,559,826 | 425,000 | -1,134,826 | $27.20M | $7.11M | 0.36% | -$20.09M |
| Immunocore Holdings plcADS(IMCR) | 200,000 | 200,000 | 0 | $6.78M | $6.23M | 0.32% | -$552.0K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 165,000 | +165,000 | $0 | $5.93M | 0.30% | +$5.93M |
| SanofiADR(SNY) | 315,000 | 100,000 | -215,000 | $15.28M | $5.76M | 0.29% | -$9.52M |
| Editas Medicine, Inc.(EDIT) | 816,000 | 1,465,000 | +649,000 | $3.81M | $5.00M | 0.25% | +$1.18M |
| TransMedics Group, Inc.(TMDX) | 0 | 27,600 | +27,600 | $0 | $4.33M | 0.22% | +$4.33M |
| Kezar Life Sciences Inc | 5,026,000 | 5,026,000 | 0 | $3.02M | $3.89M | 0.20% | +$870.5K |
| uniQure N.V.SHS(QURE) | 0 | 673,618 | +673,618 | $0 | $3.32M | 0.17% | +$3.32M |
| Immunovant, Inc.(IMVT) | 908,000 | 99,000 | -809,000 | $23.97M | $2.82M | 0.14% | -$21.15M |
| Alto Neuroscience, Inc.(ANRO) | 0 | 240,000 | +240,000 | $0 | $2.75M | 0.14% | +$2.75M |
| Prime Medicine, Inc.(PRME) | 694,000 | 694,000 | 0 | $3.57M | $2.69M | 0.14% | -$881.4K |
| Syros Pharmaceuticals Inc | 1,673,538 | 1,063,000 | -610,538 | $8.64M | $2.29M | 0.12% | -$6.35M |
| SCYNEXIS, Inc.(SCYX) | 1,448,728 | 1,448,728 | 0 | $2.90M | $2.16M | 0.11% | -$738.9K |
| Instil Bio, Inc.(TIL) | 0 | 29,100 | +29,100 | $0 | $1.96M | 0.10% | +$1.96M |
| Prelude Therapeutics Incorporated(PRLD) | 0 | 890,000 | +890,000 | $0 | $1.84M | 0.09% | +$1.84M |
| Karyopharm Therapeutics Inc.(KPTI) | 2,018,500 | 2,018,500 | 0 | $1.75M | $1.68M | 0.09% | -$75.9K |
| Hyperfine, Inc.CL A(HYPR) | 1,188,178 | 1,188,178 | 0 | $1.01M | $1.28M | 0.07% | +$273.3K |
| Bluebird Bio Inc | 0 | 1,631,143 | +1,631,143 | $0 | $847.4K | 0.04% | +$847.4K |
| Caremax IncCL A | 21,200 | 21,200 | 0 | $59.1K | $36.0K | 0.00% | -$23.1K |
| AC Immune SASHS(ACIU) | 825,000 | 0 | -825,000 | $3.29M | $0 | — | -$3.29M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 222,000 | 0 | -222,000 | $53.95M | $0 | — | -$53.95M |
| Arca Biopharma Inc | 1,000,000 | 0 | -1,000,000 | $3.83M | $0 | — | -$3.83M |
| AstraZeneca PLCADR(AZN) | 205,000 | 0 | -205,000 | $15.99M | $0 | — | -$15.99M |
| Collegium Pharmaceutical, Inc.(COLL) | 117,000 | 0 | -117,000 | $3.77M | $0 | — | -$3.77M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 215,600 | 0 | -215,600 | $9.76M | $0 | — | -$9.76M |
| Cybin D/B/A Helus Pharma(HELP) | 34,884,000 | 0 | -34,884,000 | $9.45M | $0 | — | -$9.45M |
| Gilead Sciences, Inc.(GILD) | 255,000 | 0 | -255,000 | $17.50M | $0 | — | -$17.50M |
| Immatics N.V.SHS(IMTX) | 393,100 | 0 | -393,100 | $4.57M | $0 | — | -$4.57M |
| Intellia Therapeutics, Inc.(NTLA) | 170,000 | 0 | -170,000 | $3.80M | $0 | — | -$3.80M |
| Ionis Pharmaceuticals, Inc.(IONS) | 93,000 | 0 | -93,000 | $4.43M | $0 | — | -$4.43M |
| Jasper Therapeutics, Inc.(JSPR) | 782,000 | 0 | -782,000 | $17.75M | $0 | — | -$17.75M |
| Lantheus Holdings, Inc.(LNTH) | 290,000 | 0 | -290,000 | $23.28M | $0 | — | -$23.28M |
| Legend Biotech CorporationADS(LEGN) | 398,000 | 0 | -398,000 | $17.63M | $0 | — | -$17.63M |
| Merck & Co., Inc.(MRK) | 325,000 | 0 | -325,000 | $40.23M | $0 | — | -$40.23M |
| Nuvation Bio Inc.W EXP 07 07 202(NUVB) | 12,136 | 0 | -12,136 | $1.9K | $0 | — | -$1.9K |
| Regeneron Pharmaceuticals, Inc.(REGN) | 48,000 | 0 | -48,000 | $50.45M | $0 | — | -$50.45M |
| Spyre Therapeutics, Inc.(SYRE) | 195,000 | 0 | -195,000 | $4.58M | $0 | — | -$4.58M |
| The Cigna Group(CI) | 184,500 | 0 | -184,500 | $60.99M | $0 | — | -$60.99M |